ILACIRNON
Ilacirnon is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target C-C chemokine receptor type 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
No data
Commercial
No data
Clinical
No data
Drug
General
| Drug common name | ILACIRNON |
| INN | ilacirnon |
| Description | Ilacirnon is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target C-C chemokine receptor type 2. |
| Classification | Small molecule |
| Drug class | Chemokine receptor (CCR) antagonists, not antivirals |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | Cc1cnc(C(=O)c2ncnc3[nH]ccc23)c(NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)c1 |
Identifiers
| PDB | — |
| CAS-ID | 1100318-47-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2178573 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 380F68J5PH (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
CCR2
CCR2
Organism
Homo sapiens
Gene name
CCR2
Gene synonyms
CMKBR2
NCBI Gene ID
Protein name
C-C chemokine receptor type 2
Protein synonyms
CD192, chemokine (C-C motif) receptor 2, MCP-1 receptor, MCP-1-R, Monocyte chemoattractant protein 1 receptor, monocyte chemotactic protein 1 receptor
Uniprot ID
Mouse ortholog
Ccr2 (12772)
C-C chemokine receptor type 2 (Q61172)
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use